A randomised, placebo controlled trial of omalizumab in patients with allergic bronchopulmonary aspergillosis
Latest Information Update: 15 Jan 2016
At a glance
- Drugs Omalizumab (Primary)
- Indications Aspergillosis; Invasive bronchopulmonary aspergillosis
- Focus Therapeutic Use
Most Recent Events
- 15 Jan 2016 New trial record